Mechanism of action<unk>  binds and inactivates the sodium/bile acid cotransporter, blocking both viruses from entering hepatocytes. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus's entry mechanism. The drug is also effective against hepatitis D because the hepatitis D virus is only infective in the presence of a hepatitis B virus infection.
Bulevirtide
Andexanet alfa
Vosoritide
Abaloparatide
Oprelvekin
Tirzepatide
Vonicog alfa
Etelcalcetide